Effect of risperidone on sleep in schizophrenia: a comparison with haloperidol

Psychiatry Research
Hidehisa YamashitaMasatsugu Nagao

Abstract

The aim of the present study is to determine the effect of the atypical antipsychotic drug, risperidone on sleep measures in patients with schizophrenia by polysomnography. Sleep measures were compared in five schizophrenic patients who were receiving risperidone alone and five schizophrenic patients who were receiving haloperidol alone. There were no differences between these two groups in their demographic characteristics or doses of antipsychotic medication. The slow wave sleep period was significantly longer in the risperidone-treated group than in the haloperidol-treated group. There were, however, no other significant differences in sleep variables between these groups. This difference in the effect on sleep between risperidone and haloperidol may be due to their differential actions on serotonin (5-HT2) receptors. Risperidone, which is known to be a serotonin-dopamine antagonist, has the potential to improve the quality of sleep in schizophrenic patients.

References

Jul 16, 1986·Brain Research·C IdzikowskiR Glennard
Jan 1, 1988·Psychopharmacology·T PaivaJ N Leitao
Jan 1, 1987·Pharmacology, Biochemistry, and Behavior·K SvenssonF Obál
Nov 1, 1986·Behavioral and Neural Biology·E GalarragaM Sangri
Jul 1, 1974·Archives of General Psychiatry·J KaplanR J Wyatt
Jan 1, 1993·Biological Psychiatry·Y KatsudaA L Sharpley

❮ Previous
Next ❯

Citations

Mar 23, 2004·Sleep Medicine Reviews·Jaime M Monti, Daniel Monti
Apr 15, 2008·International Clinical Psychopharmacology·Andrew D KrystalThomas Roth
Apr 2, 2009·Psychiatry and Clinical Neurosciences·Yu-San ChangMing-Chao Chen
Jan 20, 2004·CNS Drugs·Tracy Swainston Harrison, Karen L Goa
Apr 16, 2011·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·Fred HolstenBørge Sivertsen
Oct 4, 2011·Sleep·Akifumi KishiYoshiharu Yamamoto
Dec 1, 2004·Acta Neuropsychiatrica·P M Judith HaffmansAndreas Schreiner
Jan 26, 2011·The British Journal of Psychiatry : the Journal of Mental Science·Vivien BromundtChristian Cajochen
Apr 19, 2011·Sleep Medicine Clinics·Andrew D Krystal
Sep 21, 2013·International Journal of Psychiatry in Clinical Practice·Pedro AfonsoIvan Bernardo-Fernandez
Nov 30, 2002·Expert Opinion on Investigational Drugs·Stephen Brooks, Jed Black
Aug 14, 2010·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Elliott Kyung Lee, Alan B Douglass
Jul 6, 2006·International Journal of Geriatric Psychiatry·Guk-Hee SuhSung-Ku Choi
Apr 20, 2012·The Cochrane Database of Systematic Reviews·Kaushadh JayakodyShalmini Gunadasa
Mar 1, 2017·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Vassilis Cutsuridis
Oct 21, 2009·The Journal of Pharmacology and Experimental Therapeutics·Hussien A Al-ShammaDominic Behan
Nov 17, 2017·The Cochrane Database of Systematic Reviews·Edward J BryanAjit Kumar
Aug 25, 2020·Current Sleep Medicine Reports·Sadaf FarasatBiren B Kamdar
Aug 15, 2018·Medicines·Lauren StummerMegan E Maroney
Nov 19, 2019·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Mikio SuzukiTakashi Futamura
Apr 21, 2018·Schizophrenia Research and Treatment·Mohammad Zia Ul Haq KatshuS Haque Nizamie
Aug 12, 2021·Biological Psychiatry : Cognitive Neuroscience and Neuroimaging·Jin-Bo SunWei Qin
Jun 10, 2008·Critical Care Clinics·Gerald L Weinhouse

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here